Search clinical trials for: Fosamax (Alendronate)

Total 313 results

Medical University of South Carolina
Merck Sharp & Dohme LLC; FDA Office of Orphan Products Development

Completed

Alendronate in Juvenile Osteoporosis

Fractures | Juvenile Osteoporosis | Low Bone Density

United States
University of California, Davis
National Heart, Lung, and Blood Institute (NHLBI); Doris Duke Charitable Foundation

Not yet recruiting

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Osteonecrosis | Avascular Necrosis | Sickle Cell Disease | Sickle Cell Anemia | Ischemic Necrosis
Radius Health, Inc.

Completed

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis (ACTIVExtend)

Postmenopausal Osteoporosis

Poland, Hong Kong, Romania, Estonia, United States, Argentina, Brazil, Denmark, Lithuania, Czechia
National Institute of Dental and Craniofacial Research...

Completed

Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

Polyostotic Fibrous Dysplasia

United States
Ciudad Universitaria, Spain

Completed

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

Osteoporosis

Spain
Far Eastern Memorial Hospital

Unknown

Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?

Peritoneal Dialysis

Taiwan
Organon and Co

Completed

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Osteoporosis Postmenopausal
Columbia University
Merck Sharp & Dohme LLC

Withdrawn

The Effects of Alendronate After Cure of Primary Hyperparathyroidism (AlenPostPara)

Hyperparathyroidism

United States
University of Rochester

Terminated

Pilot Study of Fosamax in Spinal Cord Injury

Osteoporosis | Spinal Cord Injury

United States
Organon and Co

Completed

FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

Osteoporosis
University of California, San Francisco
Merck Sharp & Dohme LLC

Completed

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women

Osteoporosis | Osteopenia

United States
Barwon Health
AstraZeneca

Completed

Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment (BATMAN)

Breast Cancer

Australia
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg)

Healthy

United States
Teva Pharmaceuticals USA

Completed

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

Healthy

Canada
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions

Healthy

India
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)

Healthy

United States
Evangelisches Krankenhaus Lutherhaus gGmbH
German Federal Ministry of Education and Research

Terminated

Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy (BILANZ)

Osteoporosis

Germany
Department of Clinical Research and Innovation

Terminated

Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

Cerebral Palsy | Osteoporosis

France
Aristotle University Of Thessaloniki
424 General Military Hospital

Recruiting

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease (OsteoNAFLD)

Osteoporosis, Postmenopausal | Nonalcoholic Fatty Liver

Greece
University of California, San Francisco

Completed

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

Perimenopausal Bone Loss

United States
Monash University

Completed

Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease

Arteriosclerosis | Vascular Calcification

Australia
Chinese University of Hong Kong

Unknown

Fosamax for Childhood Cancer Survivors

Osteoporosis

Hong Kong
McMaster University
McGill University; Centre hospitalier de l'Université de Montréal (CHUM); University... and other collaborators

Completed

Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients

Osteoporosis | Bone Diseases, Metabolic | Cystic Fibrosis

Canada
University of Wisconsin, Madison
Wisconsin Partnership Program

Terminated

Pilot Study of Bisphosphonates for Breast Cancer

Breast Neoplasms

United States
Northwestern University
Amgen

Active, not recruiting

Romosozumab in Women With Chronic SCI

Osteoporosis | Bone Loss | Spinal Cord Injuries | Osteopenia, Osteoporosis | Chronic Spinal Paralysis

United States
Indiana University School of Medicine

Completed

Bisphosphonate Therapy for Osteogenesis Imperfecta

Osteoporosis | Osteogenesis Imperfecta | Paget Disease of Bone
Xinhua Hospital, Shanghai Jiao Tong University...

Completed

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Osteoporosis | Differentiated Thyroid Cancer

China
Medical University of South Carolina
Merck Sharp & Dohme LLC

Completed

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

Osteoporosis

United States
Tuen Mun Hospital

Completed

Denosumab Versus Bisphosphonates (Alendronate) in GIOP

Osteoporosis

China
Columbia University
Novartis Pharmaceuticals

Completed

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (CTX)

Liver Transplantation | Heart Transplantation | Bone Resorption

United States
Panineeya Mahavidyalaya Institute of Dental Sciences...

Completed

Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects.

Intrabony Periodontal Defect
Canadian Urology Research Consortium
Merck Frosst Canada Ltd.; Abbott

Terminated

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Osteoporosis
Amgen

Completed

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis (ARCH)

Postmenopausal Women With Osteoporosis

United States, Canada, Denmark, France, Germany, Italy, Belgium, Colombia, Czechia, Mexico, Poland, Russian Federation, Netherlands, Hungary, Peru, Turkey, Taiwan, Spain, Hong Kong, Austria, Slovakia, United Kingdom, South Africa, Aus... and more
Columbia University
Amgen

Completed

Bisphosphonates for Prevention of Post-Denosumab Bone Loss

Osteoporosis | IOP

United States
Chinese University of Hong Kong

Completed

RA Denosumab on Bone Microstructure Study

Rheumatoid Arthritis

Hong Kong
Yonsei University

Recruiting

Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis

Osteoporosis

Korea, Republic of
Amgen

Completed

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

Low Bone Mineral Density
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Alendronate to Prevent Loss of Bronchoprotection in Asthma (ALFA)

Asthma

United States
Labatec Pharma SA

Unknown

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

Osteoporosis, Postmenopausal

Switzerland
University of Arkansas

Terminated

Glucocorticoids Promote Osteoclast Survival

Osteoporosis

United States
Massachusetts General Hospital
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Alendronate and/or Parathyroid Hormone for Osteoporosis

Osteoporosis

United States
Medical University of South Carolina
Merck Sharp & Dohme LLC; FDA Office of Orphan Products Development

Completed

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

Osteoporosis

United States
Massachusetts General Hospital

Completed

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Hepatitis B

United States
Merck Sharp & Dohme LLC

Withdrawn

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

Osteoporosis | Postmenopausal Osteoporosis
Massachusetts General Hospital

Active, not recruiting

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Osteoporosis | Osteoporosis, Postmenopausal

United States
Organon and Co

Completed

Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)

Osteoporosis
Merck Sharp & Dohme LLC

Completed

MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

Osteoporosis | Postmenopausal Osteoporosis
University of Chicago
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Texture Analysis for Postmenopausal Osteoporosis

Osteoporosis | Osteopenia

United States
Medical University of Vienna

Completed

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis (Confors)

Osteoporosis

Austria
Aarhus University Hospital

Completed

The Effect of Effervescent Alendronate on Bone Turnover

Osteopenia or Osteoporosis

Denmark

Search clinical trials for: Fosamax (Alendronate)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations